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Cardiovascular function encounter changes on exposure to altitude. The fall in arterial blood oxygen saturation, due to low 
quantity of breathable oxygen, caused by low atmospheric pressure at high altitude, is known as High altitude hypoxia (HAH). 
The human body is capable of adapting to HAH via short- and long-term mechanisms. HAH affects the vascular tone of the 
pulmonary and systemic vessels thereby increasing ventilation, which is the first notable change at high altitude (HA).  Exposure 
to altitude increases cerebral and coronary blood flow and causes pulmonary hypertension. Pulmonary hypertension, is associated 
with a rise in pulmonary vascular resistance secondary to vasoconstriction induced by hypoxia and vascular remodeling. Initially 
exposure to HA decreases systolic blood pressure which increase when the sympathetic nervous system is activated. The increase 
in blood pressure and sympathetic nervous system activation, leads to an increase in heart rate and cardiac output, which falls to 
normal few days after acclimatization, but the increased heart rate is retained, while the stroke volume remains decreased. The 
adaptation of the cardiovascular system to chronic exposure to hypoxia involves both structural and functional changes. These 
include; persistent pulmonary hypertension, right ventricle (RV) hypertrophy, decrease in CBF and reduced fetal and 
uteroplacental volumetric blood flows. This review focuses on the adjustment of the cardiovascular system to high altitude 
exposure. 
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INTRODUCTION 
 
Humans are faced with unique challenges at high-altitude 
environments including cardiac stress (Naeije, 2010). High 
altitude (HA) is generally defined as greater than 2500 meters 
above sea level (mASL) approximately 8200ft (Leon-Velarde 
and Reeves, 1999) which is associated with lower partial 
pressure of O2 (PO2) relative to sea level. A recent estimation 
revealed that ≈83million people live at >2500 mASL, which 
includes populations mainly from South America, Central 
Asia, and Eastern Africa (Beall, 2014). These highlanders are 
chronically exposed to relative hypoxia, which has important 
consequences on the cardiovascular system and blood 
pressure (BP) regulation (Beall, 2014). 
 High-altitude hypoxia (HAH) is conventionally defined 
by the fall in arterial blood O2 saturation (SaO2) in the body at 
altitudes >2500 m (Moore et al., 2011). The hypoxemic type, 
caused by the high altitudinal low atmospheric pressure, due 
to decreased breathable oxygen quantity, resulting to low 
maximal oxygen uptake (VO2 max), and arterial partial 
pressure of O2 (PaO2) in the body (Naeije, 2010). Oxygen 
availability decrease at high altitude leads to significant 
changes in cardiovascular system functions and increased risk 
of cardiovascular diseases. Low amount of atmospheric 
oxygen can be partially compensated for, by both long-term 
and short-term adaptations to altitude by the human body 
(Wagner, 2000).  The first notable physiologic change at HA 
is hyperventilation. Several endocrine changes are induced by 
HA such as activation or inhibition of hormonal systems (Jean 
et al., 2010). Red blood cells are important players in the 
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erythropoietin. Prolonged exposure to HA leads to increased 
erythropoietin production resulting in increase in hemoglobin 
concentration increase (Naeije, 2010). 
 Adults at high altitude experience cardiovascular death as 
a leading cause of non-traumatic deaths (Burtscher and 
Ponchia, 2010). Exposure to high altitude causes the resting 
heart rate to increase relative to sea level. Also, in contrast, 
maximal heart rate is decreased (Bärtsch and Gibbs, 2007). 
The increased stroke volume observed with exercise at sea 
level is decreased at HA (Bärtsch and Gibbs, 2007, Boushel et 
al., 2001, Boos et al., 2014). Subsequently, while resting 
cardiovascular yield is higher at HA, versus ocean level, at top 
exercise it is relatively lower (Bärtsch and Gibbs, 2007, Boos 
et al., 2014, Naeije, 2010). These variables related to the huge 
diminishing in blood vessel oxygen content act to restrict top 
exercise limit and oxygen utilization (Bärtsch and Gibbs, 
2007, Naeije, 2010). Other cardiovascular reactions remember 
an expansion for resting brachial artery systolic blood pressure 
(SBP) and 24hours arterial blood pressure (BP), which in 
relation to the rise in resting pulse, could be potential 
embroiling factors in cardiovascular danger (Bilo et al., 2015). 
Systemic hypertension is influenced by environmental factors 
such as high-altitude, genetics, race and geographic location. 
Studies have focused on the acute and subacute hemodynamic 
changes in lowlanders who are suddenly exposed to HA. 
Although, little is known about the definite pathophysiologic 
mechanisms of chronic hypertension at HA, differences in the 
characteristics of chronic hypertension between various HA 
settings, or the efficacy of anti-hypertensive agents in chronic 
highlanders. People living in low-income countries, such as 
the majority of highlanders, demonstrate higher prevalence of 
non-communicable diseases, including hypertension (Islam et 
al., 2014). Although, the current extent of hypertension is 
considered as a global public health issue by the World Health 
Organization (WHO, 2017), the real burden of hypertension 
and its complications in HA locations worldwide is not well 
defined. Given the large number of highlanders around the 
world, and the well-established role of hypertension in 
cardiovascular risk, hypertension at HA is a highly relevant 
clinical and public health problem that requires increased 
awareness and study. This review presents the physiologic and 
pathologic variation of cardiovascular framework to present 
moment and long haul HA and its basic systems. 
 
High Altitude Exposure and the Cardiovascular Function 
 
Heart rate: Acute hypoxia prompts increment in 
cardiovascular yield (which falls at rest and on workout with 
acclimatization), heart rate (at rest and on work out), and 
myocardial contractility for the initial days on introduction 
(Riley and Gavin, 2017).    
 The electrocardiogram at HA shows dynamically 
expanded adequacy of P wave, right QRS axis deviation, and 
indications of RV over-burden and hypertrophy (Riley and 
Gavin, 2017). In some cases, an electrocardiogram may stay 
unaltered up to outrageous elevations (Naeije, 2010). 
Elevation and exercise might be identified with 
supraventricular and ventricular untimely pulsates, there is no 
proof of an expanded instance of hazardous arrhythmias in 
either typical subjects or patients with coronary illness 
(Bartsch and Gibbs, 2007).  
 One of the earliest responses to high altitude is increment 
in heart rate (HR). The increase is identified with increased 
sympathetic activity and vagal withdrawal (Riley and Gavin, 
2017). In a study of 139 healthy men, HR increased by 20.44 
beats per min at an altitude of 3700m compared with 500m 
(Rao et al., 2015). Although, the underlying mechanism for 
this increase, particularly during exercise, is not understood; 
undoubtedly, increased sympathetic activity and circulating 
catecholamines play essential roles in increasing HR at rest 
but few studies reported that preliminary administration of 
beta blockers can overcome this increase (Mirrakhimov and 
Winslow, 2011). In other studies, only an obstruction of both 
sympathetic and vagal activities simultaneously can totally 
overcome the rise in HR induced by hypoxia at rest 
(Siebenmann et al., 2015). Therefore, it is possible that both 
vagal withdrawal and an increase in sympathetic activity are 
responsible for the rise in resting HR with altitude. Chronic 
exposure to altitude leads to enhancement in parasympathetic 
activity, causing reduction in maximum HR. During exercise 
HR is also decreased from sea-level values (Boushel et al., 
2001). However, at rest, there are discordant data on whether 
HR is normalized or remain slightly elevated with 
acclimatization (Siebenmann and Lundby, 2015). Vagal 
withdrawal (which is important at rest) appears to play a more 
central role during exercise-induced tachycardia in hypoxia.  
 In a study by Siebenmann et al. (2015), observations 
showed that propranolol had no effect on exercise-induced 
tachycardia at altitude. Also, a combination of beta-adrenergic 
and muscarinic blockade only caused partial reversal of HR 
which suggests that other factors are involved (Siebenmann et 
al., 2015). They also observed that cardiac alpha 
adrenoceptors may respond to elevated levels of circulating 
catecholamines to control HR at HA. Animal studies also 
showed that pulmonary stretch receptors may play a role in 
regulating HR at high altitude, although the mechanisms of 
this is not fully understood and may simply be through an 
increase in sympathetic activity (Mirrakhimov and Winslow, 
2011). Further studies are required on these possibilities, 
particularly the role cardiac alpha receptors play in the 
regulation of HR in hypoxia. There is possibility also that 
endothelin-1 (ET-1) plays a role in the control of HR HA. 
Receptors for ET- 1 (a potent vasoconstrictor peptide) are 
present in cardiomyocytes (Riley and Gavin, 2017). Plasma 
ET-1 is elevated with ascent to altitude (Riley and Gavin, 
2017). Activation of the ET-1 b-type receptors in 
cardiomyocytes triggers a leak of calcium ions from the 
sarcoplasmic reticulum, delivering positive inotropic and 
chronotropic effects (Kohan et al., 2011; Karppinen et al., 
2014). Parasympathetic activity is enhanced with chronic 
exposure to HA, leading to a decrease in maximum HR. The 
change in HR during exercise is also decreased from sea-level 
values (Boushel et al., 2001). However, there are conflicting 
data at rest if HR is normalized or maintains slightly elevated 
with acclimatization (Siebenmann and Lundby, 2015). Heart 
rate variability (HRV) is another area of interest of late for 
some studies. Reduction in HRV is a common finding at HA 
as a result of increased sympathetic activity (Karinen et al., 
2012). In an investigation by Karinen et al., (2012) 
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observations revealed that HRV parameters could be used as 
a predictor of acute mountain sickness (AMS). A study by 
Mairer et al. (2013) showed a contradicting observation that 
HRV indices were not associated with the prediction of AMS 
(Mairer et al., 2013). Older subjects showed less adaptation 
and a decreased cardiovascular response to HA, suggesting 
that age may affect the increase in HR (Richalet and Lhuissier, 
2013). Altitude simulation has recently allowed researchers to 
look at how different environmental components of altitude, 
such as hypoxia and hypobaria, affect HR. One such study 
found that post-exercise resting HR was 50% higher in 
hypobaric hypoxia compared with normobaric hypoxia (Di 
Pasquale et al., 2015). This example shows that both the 
hypobaric and hypoxic components of high altitude 
environment are responsible for our physiological response 
and not hypoxia alone. 
 
Cardiac output and Stroke volume: Acute exposure to HA 
increases cardiac output (CO) to preserve O2 delivery to 
tissues. Although, maximal cardiac output remains the same 
(Ke et al., 2017) and maximum oxygen utilization (VO2 max) 
falls by 1% per 100 m above 1500m. The increase in 
cardiovascular yield is clarified by the increment in heart rate 
which might be counterbalanced by decreased stroke volume, 
which is discernible right off the bat. The role of stroke 
volume (SV) in CO increase with altitude remains 
controversial Siebenmann and Lundby (2015) which suggest 
that SV remains the same in acute hypoxia, while the results 
from studies on the subject are varied (ranging from a decrease 
(Sime et al., 1974) to increase in SV (Rao et al., 2015). An 
investigation by Rao et al., (2015) uncovered a significant 
increase in SV with acute exposure to HA from 64.65mL at 
500m to 68.09mL at 3700m in 139 healthy males. They 
hypothesize that the reason for this increase in SV is likely due 
to increased venous return due to enhanced sympathetic 
activity on vasculature. Following this acute increase in SV, 
evidence shows that chronic reduction in SV following 
acclimatization, returns CO to normal physiological levels. 
While ejection fraction is increased after time, ruling it out as 
the cause of SV reduction during (Siebenmann and Lundby, 
2015), SV reduction during acclimatization may be as a result 
of altered filling of the ventricles (Stembridge et al., 2016) 
which is likely due to decreased preload, as a result of 
pulmonary vasoconstriction (Siebenmann and Lundby, 2015). 
Blood volume rises with acclimatization due to polycythemia, 
which would alter venous return and CO, this is counteracted 
by the vascularization of tissues involved in venous return to 
normal levels (Mirrakhimov and Windslow, 2011). Maximum 
achievable CO decreases with chronic HA exposure (Wagner, 
2000; Calbet, 2003). The leading theory for this is that muscle 
function is decreased at altitude, limiting its need for increased 
blood flow. Another theory is reduced myocardial function 
due to hypoxemia with the support of in vitro experiments. In 
vivo experiments have shown that myocardial function is 
maintained up to 5000m (Stembridge et al., 2016).  
 
Blood pressure: Blood pressure (BP) changes during both 
acute and chronic altitude exposure are properly defined. 
Initially, there is a decrease in systolic BP due to hypoxic 
vasodilation, which is quickly (within a few hours) 
counteracted by the sympathetic nervous system activation, 
which raises systolic blood pressure (SBP) above sea-level 
values. Systemic hypertension is well documented (even in 
HA natives) in chronic HA exposure (Mirrakhimov and 
Windslow, 2011). A study by Lang et al. (2016) revealed that 
diastolic BP did remained unchanged between sea level and 
altitude in mildly hypertensive patients (Lang et al., 2016). 
Chronic intermittent exposure to HA causes no long-term 
effect on BP (Vinnikov et al., 2016). The increased SBP is 
evident even after moderate HA exposure. A study of 46 
healthy people showed an increase in 24-hour ambulatory BP 
after an exposure to just 2035m (Torlasco et al., 2015). There 
is enhancement in BP response of hypertensives to exercise at 
HA (Lang et al., 2016). This systemic vasoconstriction is 
crucial in the maintenance of arterial O2 concentrations 
(Bender et al., 1988), although, the increase in SBP is linear 
with plasma noradrenaline concentration (Mirrakhimov and 
Windslow, 2011) which shows the importance of sympathetic 
activity in this response. Similar to HR, simultaneous alpha 
and beta blockade does not reverse it, which implies that other 
mechanisms must partially be responsible (Bartsch and Gibb, 
2007). Compensatory polycythemia is a possibility, which 
elevates blood volume and the role of the renin-angiotensin 
system. Despite the crucial changes that have been observed, 
the effects of HA on the renin-angiotensin aldosterone system 
(RAAS) and the resulting effect on BP are widely ignored by 
some studies. Studies on RAAS at HA revealed acute decline 
in plasma levels of renin, aldosterone, and angiotensin II, but 
increase to normal levels with acclimatization (Maher et al., 
1975; Keynes et al., 1982; Parati et al., 2014; Lang et al., 
2016). The activity of renin and aldosterone also reduces 
(Lang et al., 2016; Riley and Gavin, 2017). The mechanism 
for the reduction in these components of RAAS is not known 
since the increase in sympathetic activity seen at HA in 
conjunction with renal artery vasoconstriction would be 
expected to increase plasma renin levels. Also, there are 
peculiarities in the levels of angiotensin-converting enzyme 
(ACE) at HA; a study revealed that peripheral ACE increases 
with acute altitude exposure (Kamikomaki and Nishioka, 
2004) despite several studies showing that trans-pulmonary 
ACE activity decreases (Li et al., 2016). It is known that 
RAAS inhibition is a way to regulate the increase in BP at HA, 
although it may not be as effective as it is at sea level (Parati 
et al., 2014; Lang et al., 2016). Sympathetic regulation may 
be more effective (Bilo et al., 2011).  
 
High Altitude Exposure and the Cardiovascular 
Circulation 
 
The vascular tone of the systemic and pulmonary vessels is 
influenced by hypoxia, which elevates ventilation and 
sympathetic activities by means of incitement of the peripheral 
chemoreceptors (Bärtsch and Gibbs, 2007). Associations 
happen between the immediate impacts of hypoxia on blood 
vessels and the chemoreceptor-intervened reactions in the 
systemic and pulmonary circulation. Regulation of local 
oxygen conveyance as per the necessities of the tissues is 
accomplished by several mechanisms (Singel and Stamler, 
2005; Lundberg and Weitzberg, 2005). One of such 
mechanisms is the arrival of ATP from red blood cells and the 
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production of nitric oxide (NO) by different approaches to 
control local oxygen conveyance as indicated by the 
necessities of the tissue. Extended stay at high altitude 
decreases these mechanisms when blood oxygen content is 
elevated on account of ventilatory acclimatization, a rise in 
hematocrit related with plasma volume decrease, and an 
increment in red blood cell mass because of erythropoiesis. 
Peripheral chemoreceptor afferent action rises hyperbolically 
as hypoxia builds (Marshall, 1994). Exposure ranging from 
several days to weeks elevate the sensitivity of the peripheral 
chemoreceptors to hypoxia, resulting in further improvement 
of ventilation (ventilatory acclimatization). Presumably, this 
is responsible for the further increment in sympathetic activity 
archived by micro-neurography following 3 weeks at 5200m 
(Hansen and Sander, 2003) and raised catecholamines in urine 
and plasma (Mazzeo et al., 1991). Blood pressure is reduced 
during the first few hours of exposure to HA which results 
from the nullification of sympathetic vasoconstriction in the 
systemic circulation by hypoxic vasodilatation. The blood 
pressure and systemic vascular opposition is elevated for 
about 3 to a month due to expanding sympathetic activities 
and diminished tissue hypoxia related with acclimatization. 
Oxygen administration does not fully reverse the increased 
blood pressure (Bärtsch and Gibbs, 2007) which suggests the 
involvement of additional mechanism.  
 
Coronary Circulation: On intense introduction to hypoxia, 
the epicardial coronary arteries widens. A rise in resting 
myocardial blood flow makes up for the decreased blood 
oxygen content and adds to the upkeep of cardiovascular 
capacity (Koepfli et al., 2004), while work-out instigated 
coronary flow reserve is maintained at least to 4500 m (Wyss 
et al., 2003). In a study, healthy young indicated no 
myocardial ischemia on work out during a recreated climb to 
the culmination of Mount Everest (8840 m) more than 40 days 
(Malconian et al., 1990). Following 10 days at 3100 m 
(Bärtsch and Gibbs, 2007), coronary blood flow is diminished 
which is in contrast with at sea level and in relation to the drop 
in left ventricular work because of the rise in oxygen content 
of arterial blood with acclimatization. Hence, myocardial 
oxygen extraction per volume of blood rises to keep up 
myocardial oxygenation. 
 
Pulmonary Circulation: Pulmonary hypertension is the most 
well-known impact of long-term exposure to HAH. 
Components of the vascular walls and endothelial 
dysfunction, expansion of smooth muscle into formerly non-
muscular vessels and adventitial thickening are involved in 
pulmonary vascular adaptations. 
 Oxygen breathing does not completely reverse HA 
induced pulmonary hypertension from chronic exposure to 
HA, this suggests that pulmonary arterial structural 
remodeling is crucial in pulmonary hypertension during 
chronic exposure to HA (Ke et al., 2017). Several scientific 
investigations have detailed the pervasiveness of HA 
pulmonary hypertension somewhere in the range of 5% and 
18% of the populace living at high height (Xu and Jing, 2009). 
High-altitude pulmonary hypertension is described by an 
ascent in pulmonary vascular obstruction auxiliary to hypoxia-
instigated pulmonary vasoconstriction and vascular 
remodeling. Pulmonary arteries (PAs) redesigning includes 
cell hypertrophy and hyperplasia in each of the three structural 
layers of PAs, specifically adventitia, media, and intima. Also, 
chronic exposure to HA causes other structural alterations, for 
example; relocation of medial smooth muscle cells (SMCs) 
into the intima, fibroblast multiplication and an increment in 
collagen deposition in the adventitia, increment in 
extracellular matrix proteins secretion by endothelial cells, 
and the presence of SM-like cells in formerly non-muscular 
vessels of the alveolar wall. These changes lead to a decrease 
in vascular lumen distance across and an ascent in pulmonary 
vascular opposition (Stenmark et al., 2006). The molecular 
mechanisms fundamental to the pathogenesis of high altitude-
instigated pulmonary hypertension are not completely 
understood, yet a few hypoxia-mediated signaling pathways 
are considered as players. Membrane-bound receptors in 
pulmonary vessels and signaling proteins are responsive to 
hypoxia and are significant in vascular medial multiplication. 
Recently, an examination utilizing sheep model of in utero 
exposure to chronic HAH shows that pulmonary vascular 
redesigning was like that seen in other animal models of 
pulmonary hypertension (Sheng et al., 2009). The outcome 
demonstrates that pulmonary arteries of fetuses introduced to 
chronic HAH displayed medial wall thickening and distal 
muscularization attributed to a rise in epidermal growth factor 
receptor (EGFR) protein expression in the pulmonary arteries. 
In a study, it was revealed that EGFR was crucial in fetal ovine 
pulmonary vascular redesigning following chronic HAH 
introduction and EGFR signaling restraint may invert high 
altitude-instigated pulmonary vascular redesigning.  EGFR, 
Platelet-activating factor (PAF) and PAF receptor have 
likewise been indicated in the pathogenesis of chronic 
exposure to HAH-instigated pulmonary redesigning and 
hypertension in various animal models (Ono et al., 1992, 
Bixby et al., 2007). High PAF and PAF receptor expression 
levels in pulmonary arteries have been reported in exposure to 
chronic hypoxia in animal models (Ono et al., 1992; Bixby et 
al., 2007). Changes in ionic homeostasis of pulmonary arterial 
smooth muscle cells (PASMCs) brought about by chronic 
exposure to HAH have pronounced effects on PA redesigning. 
Membrane depolarization of PASMCs following O2 sensitive 
K+ Channels inhibition ignites Ca2+ influx subsequently 
elevating cytoplasmic ionized Ca2+ through voltage-gated 
Ca2+ channels. These adjustments in potassium and calcium 
ion transport regulates these processes by altering membrane 
potential, apoptosis, gene transcription, cell-cycle progression 
and cell volume. These adaptations are involved in pulmonary 
arterial remodeling. PASMCs, despite being a major 
component of arteries actively involved in the mediation of 
maintained vasoconstriction and promotion of medial 
hypertrophy, however, endothelial cells can detect humoral 
and hemodynamic changes resulting from exposure to chronic 
HAH, thereby triggering the release of vasoactive and 
mitogenic factors that influences the growth and function of 
PASMCs (Emery, 1994, Gerasimovskaya et al., 2005, 
Stenmark et al., 2006).  
 Exposure to chronic hypoxia builds gene transcription 
and peptide synthesis of Endothelin (ET)-1, a key player in 
hypoxia-instigated pulmonary vasoconstriction and vascular 
redesigning in cultured endothelial cells (Chen and Oparil, 
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2000).  Patients with primary pulmonary hypertension have 
selectively upregulated ET-1 and its receptors and when 
exposed to HA (Chen and Oparil, 2000). Administration of ET 
receptor antagonist can prevent and reverse hypoxic 
pulmonary vascular redesigning which suggests the 
importance of ET-1 and its receptor-mediated signaling in 
chronic hypoxia-instigated pulmonary hypertension and 
vascular redesigning (Chen and Oparil, 2000).  
 
Cerebral circulation: With exposure to high altitude, there is 
a rise in cerebral blood flow (CBF). However, increased 
exposure to altitude leads to a fall to near sea level of the 
increased CBF within 1-3 weeks. This shows that time is an 
important factor during acclimatization. Generally, natives of 
HA have lower CBF values which is in contrast to sea level 
locals. The basic system in the decrease in CBF of high-
altitude occupants is because of the rise in hematocrit thus, an 
increment in arterial blood oxygen content (CaO2), this 
proposes an opposite connection between CBF and CaO2. 
Some of the mechanisms responsible for the regulation of 
CBF are hypoxic ventilator response, hypercapnic ventilatory 
response, hypoxic cerebral vasodilation and hypocapnic 
cerebral vasoconstriction (Ainslie and Subudhi, 2014).  
 Initial exposure to HA causes hypobaric hypoxia changes 
in arbiters of CBF, on account of a decrease in arterial oxygen 
tension, which is an autonomous mediator of cerebral 
arteriolar dilatation. Also, hypoxemia can excite 
hyperventilation related decline in blood vessel (arterial) 
carbon dioxide tension, this causes cerebral arterial tightening 
because of a related increment in periarteriolar PH. 
Consequently, over a couple of days of steady introduction to 
HA, the effect of arterial oxygen tension-incited limit for 
cerebral vasodilation is lessened and the degree of hypocapnia 
is enhanced. Thus, prolonged exposure to HA increases the 
hematocrit, which results in a rise in the arterial oxygen 
composition at an unaltered oxygen pressure. Notwithstanding 
these reflex reactions, CBF is likewise constrained by some 
other hypoxia-prompted changes for example, high-height 
hypoxia-initiated changes of cerebral slim thickness, hypoxia 
incited factor (HIF), nitric oxide, endothelin-1, receptive 
oxygen species (ROS), and synapses might be answerable for 
the falling CBF during long haul HAH (Ainslie and Ogoh, 
2010). 
 This change will generally diminish CBF. Accordingly, 
cerebral hemodynamics during acclimatization to elevation is 
the consequence of these homeostatic components. 
Notwithstanding these reflex reactions, CBF is likewise 
regulated by some other hypoxia-prompted changes for 
example, high-altitude hypoxia-induced changes of cerebral 
capillary density, hypoxia induced factor (HIF), nitric oxide, 
endothelin-1, reactive oxygen species (ROS), and 
neurotransmitters might be answerable for the diminishing 
CBF during long-term HAH (Ainslie and Ogoh, 2010). 
 
Uteroplacental circulation: Pregnancy, a condition 
associated with a notable increment in uterine blood flow 
which raises the oxygen conveyance and supplements to the 
developing fetus. Uteroplacental vascular resistance falls 
greatly which causes preferential direction of blood flow to 
this vascular bed, thus an increment in the uterine blood flow 
from 20–50 ml/min in the non-pregnant state to 450–800 
ml/min during pregnancy (Palmer et al., 1992). Uterine 
circulation adaptations to pregnancy are perplexing and 
predominantly accomplished through the repair of the uterine 
vasculature, reduced vasoconstrictor response, improved 
vasodilator response and diminished pressure-dependent 
myogenic reactivity. At sea level, the uterine distance across 
during pregnancy doubles because of adjustments in 
vasoreactivity, adjustments in the active and passive 
properties of the uterine artery and vascular growth and 
refurbishment. Although, the underlying molecular 
mechanism for uterine vascular development and expansion 
of the vascular diameter are not completely perceived. 
However, hormonal stimuli might be one of the significant 
components responsible for pregnancy-interceded diminished 
uterine vascular resistance. Estradiol has been reported to be a 
vital participant in light of its angiogenic properties and 
stimulatory impacts on nitric oxide-interceded vasodilation 
(Burton et al., 2004).  
 Estrogen receptors (ERs) have been recognized in uterine 
artery vascular smooth muscle with notable increment in their 
expressions in pregnant uterine arteries which is in contrast 
with non-pregnant uterine arteries (Chang et al., 2010). 
Pregnancy-related increment in ER assessment may directly 
increase vascular endothelial growth factor (VEGF), mitogen-
activated protein (MAP) kinase, and endothelial nitric oxide 
synthase (eNOS) expression and their activities prompting 
improved uterine vascular development and vasodilation 
(Chang et al., 2010). Diminished uterine vascular obstruction 
can likewise be controlled by contractile agonists or associated 
proteins. Also, myogenic tone and distensibility are extra 
factors that can adjust uterine arterial intraluminal diameter 
and uterine vascular resistance. It has been accounted for that 
pregnancy significantly decrease pressure-dependent 
myogenic tone, increasing the pressure-dependent passive 
uterine arterial diameter. The decreased myogenic tone is 
interceded by an increment in the inhibitory impact of 
extracellular-signal regulated kinase (ERK) and a decline in 
the protein kinase C (PKC) signalling pathway (Xiao et al., 
2006). 
 Exposure to high-altitude has profound impacts on 
uteroplacental circulation which includes alterations in 
uteroplacental and fetal blood flow volume, which results in 
fetal intrauterine development limitation. In an investigation 
by Julian et al. 2008, HAH decreases pregnancy-associated 
uterine blood flow increase (Julian et al., 2008). Decreased 
uterine blood flow and insufficient perfusion of the placenta 
has been ascribed to the rise in the cases of preeclampsia and 
fetal intrauterine development limitation (Moore et al., 2011). 
One of the systems that adds to the diminished uterine blood 
flow might be a critical restraint of pregnancy-related 
increment in uterine vascular development. The proliferative 
reaction to serum stimulation in cultured uterine arterial 
smooth muscle cells is also diminished by hypoxia 
introduction (Rockwell et al., 2006).. Also, HAH can modify 
pregnancy-associated reactions to contractile proteins and 
vasodilator-intervened signaling pathways. Report has 
indicated that, long-term exposure of sheep to high-altitude 
during pregnancy demonstrated noteworthy increment in the 
pressure-dependent myogenic tone of resistance-sized uterine 
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arteries by subduing the ERK1/2 activity and an increment in 
the PKC signaling pathway (Chang et al., 2010). Furthermore, 
HAH exposure specifically downregulates estrogen-α 
receptor expression in the uterine arteries of pregnant animals 
and hindered steroid hormone-intervened adaptation of 
ERK1/2 and PKC signaling pathways raising the myogenic 
tone of the uterine arteries in pregnancy (Chang et al., 2010). 
Huge-conductance Ca2+-activated K+ (BKca) is richly 
expressed in vascular smooth muscle cells. The BKca channel, 
a significant effector in reaction to hypoxia in vascular smooth 
muscle has been proposed to be associated in the control of 
uterine circulation and uterine blood flow increment during 
pregnancy (Rosenfold et al., 2005). Proof from pregnant sheep 
model exposed to long-term HA (about 3801 m) proved that, 
long-term HAH during pregnancy adversely influences the 
uterine circulation by decreasing BKca channel function in 
uterine vasculatures (Hu et al., 2012). During human 
development, HAH significantly restrains pregnancy-related 
increase of BKca channel action and diminishes BKca channel 
current density in pregnant uterine arteries (Hu et al., 2012). 
 This was mediated by a selective decline of BKca channel 
β1 subunit appearance in the uterine arteries. Likewise, high-
altitude hypoxia impeded the part of BKca channel in 
controlling pressure-instigated myogenic tone of uterine 
arteries which was improved in pregnant animals accustomed 
to HA. These outcomes propose that specifically focusing on 
BKca channel might be another key component in the 
maladaptation of uteroplacental circulation brought about by 
HAH, which may add to the diminished uterine blood flow 
and fetal intrauterine development limitation related with 
maternal hypoxia. The molecular mechanisms underlying HA 
hypoxia-intervened modification of targeting gene expression 
in pregnant uterine arteries are not totally perceived. 
Although, studies recommend that epigenetic system assumes 
a critical function in the control of gene expression in 
adaptation to HA (Chen et al., 2015).  
 Chronic hypoxia is responsible for the increment in 
estrogen receptor α subunit (ER-α), promotes DNA 
methylation at both upstream stimulatory factor binding sites 
and specific protein-1, diminished specificity protein-1 and 
upstream stimulatory factor binding to the promoter, and 
reduce ER-α expression in uterine arteries of pregnant animals 
(Chen et al., 2015). Additionally, proof shows that hypoxia-
interceded DNA methylation assumes an irregular function in 
ER-α gene repression and deletion of estrogen-mediated 
adaptation of uterine arterial BKca channel activity, leading to 
an increment in uterine arterial myogenic tone during 
pregnancy (Chen et al., 2015). Noteworthy contrasts can be 
seen in the uterine arterial adaptation to pregnancy dependent 
on the term of exposure to HA. Birth weight of children 
destined to Tibetan occupants at high altitude is higher than 
that of destined to Han ladies living at a similar elevation, 
which is related with an increase uterine flow velocity and 
increased uterine arterial diameters (Moore et al., 2011).  
Andean pregnant women have almost doubled increase in 
their uterine arterial diameters at HA while, European 
pregnant ladies have about half as much increment (Niermeyer 
et al., 2007). Thus, Andean pregnant ladies have higher 
uterine blood flow and birth weight than Europeans at HA. 
However, at sea level, the values are equivalent in both 
Andean and European ladies, this recommends a higher 
defensive impact of Andean family line at high altitude. 
Reports suggest that genetics are crucial in altitude-associated 
modifications in birth weight and uterine blood flow (Moore 
et al., 2011). 
 
Conclusion  
Cardiovascular adaptation to altitude varies, depending on 
individual predisposition, pace of climb and term of exposure. 
The initial response to HAH exposure is hyperventilation and 
increase in sympathetic activity (which results partly from 
chemoreceptor reflexes and baroreceptor function) leading to 
increase in heart rate, systemic vascular resistance, blood 
pressure, cardiac output and pulmonary hypertension 
associated with pulmonary vasoconstriction. A great part of 
the individual inconstancy is needy upon the seriousness of 
related pulmonary hypertension, which is frequently gentle 
yet might be extreme in an extent of cases.  In response to 
HAH, CBF increases to guarantee satisfactory supply of 
oxygen to the cerebral tissues. 
 Cardiovascular adaptation includes changes in vascular 
structures, redesigning and functional proteins through 
various molecular mechanisms such as epigenetic regulatory 
as well as genetic factor instigated mechanisms. Adaptations 
to HAH involves both compensatory and pathologic 
mechanisms. Maladaptation such as; pulmonary hypertension, 
pulmonary edema, heart failure, cerebral edema, chronic 
mountain sickness, and fetal intrauterine growth restriction 
develops from pathologic adaptations. 
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